Ng Kai-on. / "July 2001." / Thesis (Ph.D.)--Chinese University of Hong Kong, 2001. / Includes bibliographical references (p. 162-180). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Mode of access: World Wide Web. / Abstracts in English and Chinese.

Chez les organismes multicellulaires la diversité protéique dans chaque cellule et chaque tissu est obtenue initialement en régulant l’expression d’une partie des gènes d’un génome. Ces gènes sélectionnés peuvent ensuite être soumis à un épissage alternatif de sorte que certains exons sont retenus ou exclus dans l’ARNm final. Nous étudions les détails moléculaires de la protéine MEC-8, un facteur d’épissage tissu spécifique chez Caenorhabditis elegans. Les mutants MEC-8 sont responsables d’un phénotype insensible au touché chez Caenorhabditis elegans. Plus précisément, MEC-8 lie le pré-ARNm de mec-2 un composant des récepteurs mécanosensoriels afin de réguler la production d’un isoforme particulier nécessaire pour la transduction du signal mécanosensoriel. Des études portant sur le motif conservé de reconnaissance à l’ARN (RRM) chez des orthologues des vertébrés (RBPMS) et des insectes (couch potato, CPO) ont démontré la présence d’un motif d’homodimérisation dans le domaine RRM1 de MEC-8. Cependant MEC-8 contient aussi un second domaine RRM dans sa partie C-terminale, domaine qui n’est pas retrouvé dans les protéines RBPMS et CPO. Nous avons donc exprimé chaque domaine RRM de MEC-8 indépendamment ainsi que la protéine entière et ces constructions ont été utilisées pour diverses expériences biophysiques. Nous avons ainsi identifié la séquence de liaison optimale pour les deux domaines RRM1 et RRM2. Ces analyses ont aussi été menées sur les domaines homologues issus des protéines RBPMS et CPO qui présentent une forte affinité pour la même séquence d’ARN. Nous avons donc découvert que malgré des différences de fonction et de localisation les membres de la famille RBPMS lient tous le même motif d’ARN. Les détails atomiques des deux RRM en complexe avec leur motif de liaison ont été obtenus en utilisant de la spectroscopie RMN et de la cristallographique des rayons X. Les deux complexes RRM-ligand de MEC-8 présentent de surprenantes similarités dans leur architecture. / In multicellular organisms, proteomic diversity in each cell and tissue is provided initially by selective expression of gene subsets from the total genome, which are further subjected to alternative splicing, such that a different pattern of exons can be retained or excluded in the final protein coding mRNA. We are investigating the molecular details of the tissue-specific splicing factor protein MEC-8 from the worm Caenorhabditis elegans. The MEC-8 mutant protein is responsible for a touch insensitive phenotype in Caenorhabditis elegans, relating to its role as an alternative splicing factor. More precisely, MEC-8 can bind to the mec-2 pre-mRNA, a component of mechanosensory receptor, to regulate the production of a certain isoform required for transducing the touch signal. Previous studies of the conserved RNA Recognition Motif (RRM) domain in orthologues from vertebrate (RBPMS) and insect (couch potato; CPO) have demonstrated a homodimerization motif in MEC-8 RRM1. However, MEC-8 also contains a second RRM domain in the C-terminus that is not found in the characterized RBPMS and CPO proteins. We have therefore expressed the independent RNA-binding domains of MEC-8 as well as the full-length protein and have used these constructs in a variety of biophysical assays. We identified the optimal RNA binding sequence for both the RRM1 and RRM2, and quantified the penalty of sequence variations. The investigation has also been extended to the homologous domains from human RBPMS and Drosophila CPO, which show a high affinity to the same RNA sequence. We therefore find that despite differences in function and localization, the members of the RBPMS protein family all bind to the same RNA motif. Atomic details of binding have also been obtained by using a combination of NMR spectroscopy and X-ray crystallography. The ligand-bound complexes reveal a surprising similarity in the architecture of the bound ligand for the first and second RRM domains from MEC-8.

Mitochondria are important cellular organelles whose functions include generation of ATP, sequestration and release of pro-apoptotic molecules and calcium buffering. Mitochondria function is tightly linked to organelle morphology, which exits in a dynamic spectrum between a highly interconnected/fused mitochondria network to a punctate/fragmented scattering of individual mitochondrion. A family of large GTPase enzymes modulates this spectrum, with fusion catalyzed through the actions of mitofusin 1 and 2 (Mfn1/2) on the outer mitochondria membrane (OMM) and optic atrophy 1 (Opa1) causing fusion of the inner mitochondria membrane (IMM). On the other end of the spectrum, fragmentation is catalyzed through the actions of dynamin-related protein 1 (Drp1). Drp1 is recruited from the cytosol to binding partners at the OMM, organizes into concentric spiral rings, undergoes GTP hydrolysis to constrict the ring and pinches mitochondrion in two. While fragmentation is achieved through the action of only one GTPase enzyme, the mechanisms behind the complex regulation of Drp1 remain relatively obscure. In order to expand upon known Drp1 regulatory mechanisms, an examination of how both Drp1 splicing and Drp1 recruitment to the OMM contributes to protein regulation is necessary. Drp1 contains three alternatively spliced exons, resulting in the potential generation of eight protein isoforms. Each of these isoforms is capable of inducing mitochondrial fragmentation, however one exon arrangement (termed Drp1-x01) can also bind to microtubules within the cell. Characterization of the Drp1-x01 isoform at both the RNA and protein level indicate an important, yet incompletely characterized, role in immune system biology. Drp1 is capable of interacting with several proteins localized at the OMM. Among these, mitochondria fission factor (Mff) has been implicated in the formation of Drp1 spirals and the eventual fragmentation process. Mff contains four alternatively spliced exons as well as several phosphorylation sites identified through nonbiased phosphoproteomic screens. Inclusion of alternative exons to the Mff structure decreases its ability to recruit Drp1 from the cytosol, while phosphomimetic substitutions to conserved serine residues enhances the Drp1::Mff interaction. Taken together, this suggests that regulation of mitochondrial fragmentation occurs at the pretranslational (alternative splicing) and the posttranslational (phosphorylation) level is critical for maintaining the complex, yet essential, balance between mitochondrial fission and fragmentation.

<p>This review article presents the splicing process during messenger RNA maturation and how it is regulated by different <em>Cis</em>-regulatory RNA-sequence elements and splicing factors. A more detailed description of the process alternative splicing and its importance to the function of genes from the model organism <em>Arabidopsis thaliana</em> is also given. A single eukaryotic gene can by the process alternative splicing (AS) give rise to a number of functionally mature mRNA-molecules, which in turn encodes for structurally and/or functionally different proteins. During the course of evolution, the process alternative splicing has thus shown to be effective in increasing transcriptome and proteome diversity of most eukaryotic organisms. This suggests therefore that the dominant theory in molecular biology, a gene encodes for a protein, needs to be corrected. A future challenge is to determine the function of the proteins obtained from a given gene by alternative splicing.</p>

Most human genes undergo alternative splicing, and many abnormal splicing processes are associated with human diseases. However, the molecular relationship between alternative splicing and tumorigenesis is not well understood. Here, we identified novel Krüppel-like factor 4 (KLF4) splicing variants produced by exon skipping in human cancer cell lines as well as colon tumor tissues. To elucidate the mechanism involved in KLF4 alternative splicing, we developed KLF4 minigene system and found that RNA binding motif protein 5 (RBM5) plays an important role in KLF4 splicing, as assessed by gain and loss of functional studies. Several anti-tumorigenic compounds were also tested for KLF4 splicing. Interestingly, sulindac sulfide restored wild type KLF4 (KLF4L) expression and this is mediated by dephosphorylation of RBM5. Another splicing variant, small KLF4 (KLF4S), localizes in the cytoplasm and nucleus, and antagonizes transcriptional activity of wild type KLF4. Our data suggest that RBM5 plays a pivotal role in the alternative splicing of KLF4, and these splicing variant forms may impact tumorigenesis.

<p>Alternative mRNA processing can result in the generation of multiple, qualitatively different RNA transcripts from the same gene and is a powerful engine of complexity in higher organisms. Recent deep sequencing studies have indicated that essentially all human genes containing more than a single exon generate multiple RNA transcripts. Functional roles of alternative processing have been established in virtually all areas of biological regulation, particularly in development and cancer. Changes in alternative mRNA processing can now be detected from over a billion dollars' worth of conventional gene expression microarray data archived over the past 20 years using a program we created called SplicerAV. Application of SplicerAV to publicly available microarray data has granted new insights into previously existing studies of oncogene over-expression and clinical cancer prognosis.</p> <p>Adaptation of SplicerAV to the new Affymetrix Human Exon arrays has resulted in the creation of SplicerEX, the first program that can automatically categorize microarray detected changes in alternative processing into biologically pertinent categories. We use SplicerEX's automatic event categorization to identify changes in global mRNA processing during B cell transformation and show that the conventional U133 platform is able to detect 3' located changes in mRNA processing five times more frequently than the Human Exon array.</p> / Dissertation

SWI/SNF is a chromatin-remodeling complex and Brahma (BRM) is the ATPase subunit of SWI/SNF. BRM regulates transcription by remodeling the nucleosomes at promoter regions. BRM is also associated with RNA and affects pre-mRNA processing together with other SWI/SNF subunits. In this thesis, I will discuss the roles of BRM in both transcription and pre-mRNA processing. In Paper I, we showed that BRM, as well as other SWI/SNF subunits SNR1 and MOR, affects the alternative processing of a subset of pre-mRNAs, as shown by microarray analysis. This observation was validated by RNAi experiments both in Drosophila S2 cells and in vivo. In Paper II, we characterized the trans-splicing of transcripts derived from the mod(mdg4) gene. RNA interference (RNAi) and overexpression experiments revealed that BRM regulates the trans-splicing of mod(mdg4)-RX in an ATPase independent manner. In Paper III, we analyzed the expression of two BRM-target genes identified in Paper I, CG44250 and CG44251. RNAi and overexpression experiments showed that the expression levels of these two genes were affected by BRM in a manner that is independent of its ATPase activity. Transcriptome analysis further proved that BRM affects gene expression both in ATPase dependent and independent manners. In Paper IV, we showed that BRM is present at the 3’-end of two analyzed genes, CG5174 and CG2051. BRM facilitates the recruitment of the cleavage and polyadenylation machinery to the cleavage sites through protein-protein interactions that do not require the ATPase activity of BRM. Morevoer, BRM promotes the cleavage of the CG5174 and CG2051 pre-mRNAs. To sum up, SWI/SNF plays important roles not only in transcription but also in pre-mRNA processing. To regulate transcription, BRM can either act as an ATPase-dependent chromatin remodeler or in a manner that does not involve ATPase activity. Additionally, BRM interacts with RNA-binding proteins to regulate the processing of a subset of pre-mRNAs, and this function of BRM is independent of its chromatin remodeling activity. / <p>At the time of the doctoral defense, the following papers were unpublished and had a status as follows: Paper 3: Manuscript. Paper 4: Manuscript.</p>

C3d is a sub-fragment of the C3 component of the complement system.  Covalent binding of multiple C3ds to antigen reduces the activation threshold of cognate B lymphocytes by one thousand fold through co-ligation of the BCR and complement receptor 2 (CR2/CD21). Reverse transcriptase polymerase chain reaction (RT-PCR), revealed that, in cattle, four distinct complement receptors are produced from the Cr2 gene by alternative splicing. Cattle express two major variants of the Cr2 gene representing homologues of murine CR1 and CR2, each of which are expressed in both a long and a short form. Expression of CR1 was detected in splenocytes but not in splenic mononuclear cells or monocyte derived macrophages. CR2 was detected only on IgM+ blood cells and unsorted splenocytes but not in CD3+ cells, CD14+ cells or neutrophils. Additionally, the coding sequence of CD19, the CR2 co-signaling molecule was found.

No description available.

The steroid receptor RNA activator gene (SRA1) generates two distinct entities. SRA RNA coactivates several NRs whereas SRA protein (SRAP) is suspected to regulate the activity of several transcription factors, including estrogen receptors (ER). Splicing of SRA intron-1 is the major event defining SRAP coding frame. Fully spliced, coding SRA and intron-1 retained, non-coding SRA coexist in breast cancer cells. The relative proportion between the two types of SRA RNA maintains a balance between two genetically linked entities, SRA and SRAP. In this study, a minigene model was used to demonstrate that the primary sequence of SRA exon-1-intron-1-exon-2 is sufficient for alternative splicing of SRA intron-1. In addition, a modified oligoribonucleotidic construct promotes SRA intron-1 retention in breast cancer cells. This oligoribonucleotide differentially alters estradiol-induced transcription of ER regulated genes. Together, results presented herein demonstrate that the SRA-SRAP balance, which can be artificially modified by targeting alternative splicing of SRA intron-1, might be a new critical target to treat breast cancer patients.